Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide for Adults With Pulmonary NTM Infection
NCT03748992Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2019
- Primary completion
- Mar 2020
- Modality
- Transdermal Patches, Inhalation Devices, Hydrogel Systems
- Countries
- 1
01
Overview
A Phase 2 trial of Nitric oxide-releasing solution in nontuberculous mycobacterial lung disease, sponsored by Medical University of South Carolina. Started Jan 2019; status: completed.
02
Drugs
Nitric oxide-releasing solution
03
Conditions
nontuberculous mycobacterial lung disease
Beyond the preview
Go deeper on NCT03748992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03748992.